BEGIN:VCALENDAR
PRODID:-//AT Content Types//AT Event//EN
VERSION:2.0
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20120523T215045Z
CREATED:20090313T083854Z
UID:ATEvent-71b3f23c726dca3cfbdf3356f9310497
LAST-MODIFIED:20090313T105707Z
SUMMARY:CHI’s Trends in Cancer Diagnostics
DTSTART:20090810T070000Z
DTEND:20090811T070000Z
DESCRIPTION:Tremendous progress is being made in cancer diagnostics\, 
 and the proliferation of novel tests is truly historic. Gene expressio
 n panels from microarray data and next-generation sequencing are being
  used for the early detection and prognosis of cancer. Tumor aggressiv
 eness and therapy selection are being determined by these technologies
 \, and the number of companies competing in this space is growing rapi
 dly. Plan to attend to learn key factors in implementation and adoptio
 n\, and gather intelligence about the types of assays from experts in 
 the field.
LOCATION:Ritz-Carlton Hotel
CATEGORIES:Conference
CONTACT:CHI Representative\, 781-972-5400\, chi@healthtech.com
URL:http://www.healthtech.com/cdx/overview.aspx?c=592
CLASS:PUBLIC
END:VEVENT
END:VCALENDAR